{"path":".obsidian/plugins/text-extractor/cache/d6dec6e9f0d5aecc99e4666c7f296fd8.json","text":"NH, \" N o & \\ st AQQ*) . p= KN Active b =S Expiry Date ©/ HG OH 2031.07.22 Remdesivir Gilead science Approved (2020) RNA-dependent RNA Polymerase (RdRp) Injection (i.v.) Paxlovid: Hn-OH F33§ o} (PF-07321332 with A\\ N © ritonavir) N o 4 : LA M~ § o N\"So AN T NN o N ¥ ﬁi H HO OH i . Molnupiravir PF-07321332 (Nirmatrelvir) Merck Pfizer Approved (Nov. 4, 2021, UK) Approved (Dec. 22, 2021) RNA-dependent RNA Polymerase (RdRp) Main protease (Mpro, 3CLpro) Induction of lethal mutagenesis Inhibit Mpro & prevent the release of viral proteins Oral 27/90 b = Oral","libVersion":"0.2.0","langs":"eng"}